Search research articles
Contact Us
Filters
Showing results (201-210 of 219) with videos related to
Page
of 22
Sort By:
Journal of Crohn'S & Colitis
|
May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
Robert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Annals of the New York Academy of Sciences
|
November 16, 2001
Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy
R K Ngan, W H Lau, T T Yip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Population-based Screening for <i>BRAF</i> <sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
Jenny E Chu, Benny Johnson, Laveniya Kugathasan, et al.
Frontiers in Plant Science
|
July 27, 2016
Soybean Cyst Nematode Resistance Emerged via Artificial Selection of Duplicated Serine Hydroxymethyltransferase Genes
Xiao-Yi Wu, Guang-Can Zhou, Yun-Xia Chen, et al.
JCI Insight
|
January 5, 2021
Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry
Luciano Galdieri, Arijita Jash, Olga Malkova, et al.
Nature Chemical Biology
|
February 19, 2021
Optical control of fast and processive engineered myosins in vitro and in living cells
Paul V Ruijgrok, Rajarshi P Ghosh, Sasha Zemsky, et al.
Urology
|
December 5, 2020
Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy
Carissa E Chu, Lauren Law, Kyle Zuniga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Carissa E Chu, Martin Sjöström, Emily A Egusa, et al.
European Urology Oncology
|
June 30, 2026
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab
Kevin R Reyes, Ryan Zhu, Cameron Herberts, et al.
European Urology Oncology
|
February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells
Jonathan Chou, Kai Trepka, Martin Sjöström, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 219) with videos related to
Sort By:
Page
of 22
Journal of Crohn'S & Colitis
|
May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
Robert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Annals of the New York Academy of Sciences
|
November 16, 2001
Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy
R K Ngan, W H Lau, T T Yip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Population-based Screening for <i>BRAF</i> <sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
Jenny E Chu, Benny Johnson, Laveniya Kugathasan, et al.
Frontiers in Plant Science
|
July 27, 2016
Soybean Cyst Nematode Resistance Emerged via Artificial Selection of Duplicated Serine Hydroxymethyltransferase Genes
Xiao-Yi Wu, Guang-Can Zhou, Yun-Xia Chen, et al.
JCI Insight
|
January 5, 2021
Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry
Luciano Galdieri, Arijita Jash, Olga Malkova, et al.
Nature Chemical Biology
|
February 19, 2021
Optical control of fast and processive engineered myosins in vitro and in living cells
Paul V Ruijgrok, Rajarshi P Ghosh, Sasha Zemsky, et al.
Urology
|
December 5, 2020
Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy
Carissa E Chu, Lauren Law, Kyle Zuniga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Carissa E Chu, Martin Sjöström, Emily A Egusa, et al.
European Urology Oncology
|
June 30, 2026
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab
Kevin R Reyes, Ryan Zhu, Cameron Herberts, et al.
European Urology Oncology
|
February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells
Jonathan Chou, Kai Trepka, Martin Sjöström, et al.
Page
of 22